Resistance mechanisms in KRAS-G12C-mutated cancer

被引：0
|
作者：
Gassa, Asmae [1 ]
Ozkan, Filiz [2 ,3 ]
Ast, David [4 ]
Wahlers, Thorsten [1 ]
Bruns, Christiane [5 ]
Alakus, Hakan [5 ]
机构：
[1] Univ Klinikum Koln AoR, Klin & Poliklin Herzchirurg Herzchirurg Intens Me, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Med Mannheim, Sekt Pneumol, Med Klin 1, Mannheim, Germany
[3] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA
[4] Univ Cologne, Inst Pathol, Univ Klinikum Koln AoR, Mol,Pathol, Cologne, Germany
[5] Univ Klinikum Koln AoR, Klin & Poliklin Allgemein Viszeral & Tumorchirug, Cologne, Germany
来源：
ONKOLOGE | 2021年 / 27卷 / 12期
关键词：
D O I：
10.1007/s00761-021-01038-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [31] Aurora A kinase inhibition with VIC-1911 overcomes intrinsic and acquired resistance to KRASG12C inhibition in KRAS(G12C)-mutated lung cancer
    Lee, Jong Woo
    Kim, Sundong
    Yang, Cindy
    Burtness, Barbara
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [32] KRAS G12C mutated lung adenocarcinomas: a morphological and molecular cartography
    Pirlog, R.
    Piton, N.
    Marguet, F.
    Lamy, A.
    Sabourin, J.
    VIRCHOWS ARCHIV, 2021, 479 : S162 - S162
  • [33] Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas
    Pirlog, Radu
    Piton, Nicolas
    Lamy, Aude
    Guisier, Florian
    Berindan-Neagoe, Ioana
    Sabourin, Jean-Christophe
    Marguet, Florent
    CANCERS, 2022, 14 (04)
  • [34] Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer
    Fakih, Marwan
    Tu, Huakang
    Hsu, Hil
    Aggarwal, Shivani
    Chan, Emily
    Rehn, Marko
    Chia, Victoria
    Kopetz, Scott
    ONCOLOGIST, 2022, 27 (08): : 663 - 674
  • [35] Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC)
    Hong, David S.
    Kuboki, Yasutoshi
    Yaeger, Rona
    Strickler, John H.
    Masuishi, Toshiki
    Langer, Corey
    Shergill, Ardaman
    Kim, Edward
    Hindoyan, Antreas
    Tran, Qui
    Mukundan, Lata
    Chan, Emily
    Anderson, Abraham
    Fakih, Marwan G.
    CANCER RESEARCH, 2023, 83 (07)
  • [36] Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100
    Prenen, H.
    Fakih, M.
    Falchook, G.
    Strickler, J.
    Hindoyan, A.
    Anderson, A.
    Ang, A.
    Kurata, T.
    Price, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S373 - S373
  • [37] Mechanisms of acquired resistance to EGFR tyrosine kinase inhibitor osimertinib and KRAS-G12C inhibitor sotorasib in lung cancer
    Yagami, Yuri
    Sato, Takashi
    Yamamoto, Hiroki
    Shirasawa, Masayuki
    Nakahara, Yoshiro
    Hideo, Watanabe
    Katsuhiko, Naoki
    CANCER RESEARCH, 2024, 84 (06)
  • [38] The immunotherapy role in patients (pt) with KRAS mutated metastatic non-small cell lung cancer (NSCLC): Differences between KRAS G12C and non-G12C
    Notario Rincon, L.
    Pous, A.
    Lopez-Paradis, A.
    Cerda, G.
    Cucurull, M.
    Hernandez, A.
    Domenech, M.
    Carcereny, E.
    Moran Bueno, M. T.
    Munoz, A.
    Mate, J. L.
    Sanz, C.
    Saigi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S50 - S50
  • [39] Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
    Mohanty, Atish
    Nam, Arin
    Srivastava, Saumya
    Jones, Jeff
    Lomenick, Brett
    Singhal, Sharad S.
    Guo, Linlin
    Cho, Hyejin
    Li, Aimin
    Behal, Amita
    Mirzapoiazova, Tamara
    Massarelli, Erminia
    Koczywas, Marianna
    Arvanitis, Leonidas D.
    Walser, Tonya
    Villaflor, Victoria
    Hamilton, Stanley
    Mambetsariev, Isa
    Sattler, Martin
    Nasser, Mohd W.
    Jain, Maneesh
    Batra, Surinder K.
    Soldi, Raffaella
    Sharma, Sunil
    Fakih, Marwan
    Mohanty, Saswat Kumar
    Mainan, Avijit
    Wu, Xiwei
    Chen, Yihong
    He, Yanan
    Chou, Tsui-Fen
    Roy, Susmita
    Orban, John
    Kulkarni, Prakash
    Salgia, Ravi
    SCIENCE ADVANCES, 2023, 9 (41)
  • [40] Establishment of KRAS G12C mutated colorectal cancer cells and drug screening for the combination therapy.
    Maruyama, Kohei
    Shimizu, Yuki
    Oh-hara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2021, 112 : 799 - 799
12345